Loading...

Celyad Oncology SA

CYAD.BR•EURONEXT
Healthcare
Biotechnology
€0.35
€-0.02(-4.37%)

Celyad Oncology SA (CYAD.BR) Stock Chart & Performance Analysis

Explore Celyad Oncology SA’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
6.82%
5-Day Change
-2.08%
1-Month Change
3.18%
3-Month Change
-9.62%
6-Month Change
79.73%
Year-to-Date (YTD) Change
-29.85%
1-Year Change
41.14%
3-Year Change
-77.99%
5-Year Change
-94.20%
All-Time (Max) Change
-97.18%

Analyzing Celyad Oncology SA (CYAD.BR) Trends Across Multiple Time Frames

Celyad Oncology SA Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Celyad Oncology SA stock shows 6.82% 1-day change, indicating immediate volatility, while its 5-day change of -2.08% suggests a broader trend. Over a 1-month period, a 3.18% rise could signal a pushback, whereas a 3-month decline of -9.62% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of 79.73% and a YTD drop of -29.85% might concern investors, but a 1-year gain of 41.14% and a 3-year drop of -77.99% could indicate resilience. The 5-year surge of -94.20% highlights weak historical growth, while the all-time return of -97.18% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;